8-K FOR BVF COMMON SHARE EXCHANGE AGREEMENT

Company

Eledon Pharmaceuticals, Inc.

Filed

January 13, 2022

Period of Report

January 11, 2022

Accession Number

0001564590-22-001203

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →